Ray Andersen's research on the marine sponge Geodia lindgreni from Papua New Guinea

Prostate cancer drug enters clinical trials from UBC News Release:

"Developed by Marianne Sadar, a researcher with UBC Pathology and Laboratory Medicine and a distinguished scientist at the BCCA, and Raymond Andersen in the departments of Chemistry and Earth, Ocean and Atmospheric Sciences, EPI-506 was specifically designed to target and shut down metastatic castrate resistant prostate cancer when other treatments fail...The lead compound of the drug was sourced from a marine sponge extract, and designed and synthesized in Andersen's lab. Andersen is known for his research into the structure of novel chemical compounds derived from marine organisms, the molecular routes to their biosynthesis, their role in ocean ecology and their potential as new drugs."

For the full article and a video clip, see:http://science.ubc.ca/news/made-bc-prostate-cancer-drug-enters-clinical-....